The psychosocial determinants of quality of life in breast cancer survivors: a scoping review von Culbertson, Michael G, Bennett, Kathleen, Kelly, Catherine M, Sharp, Linda, Cahir, Caitriona

Volltext

Overview of recent advances in metastatic triple negative breast cancer von O'Reilly, David, Sendi, Maha Al, Kelly, Catherine M

Volltext

Estrogen and HER‐2 Receptor Discordance Between Primary Breast Cancer and Metastasis von Pusztai, Lajos, Viale, Giuseppe, Kelly, Catherine M., Hudis, Clifford A.

Volltext

Cost‐Effectiveness Analysis of Recurrence Score‐Guided Treatment Using a 21‐Gene Assay in Early Breast Cancer von Tsoi, Daphne T., Inoue, Miho, Kelly, Catherine M., Verma, Sunil, Pritchard, Kathleen I.

Volltext

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers von Kelly, Catherine M., Krishnamurthy, Savitri, Bianchini, Giampaolo, Litton, Jennifer K., Gonzalez‐Angulo, Ana M., Hortobagyi, Gabriel N., Pusztai, Lajos

Volltext

Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy von Giblin, Gerard T., Dennehy, Colum, Featherstone, Hannah, Clarke, Rachel, Murphy, Laura, Timlin, Deirdre, O’Keane, Conor, Mulligan, Niall, Kelly, Catherine M., Joyce, Emer

Volltext

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland von McSorley, Lynda M, Tharmabala, Mehala, Al Rahbi, Fathiya, Keane, Fergus, Evoy, Denis, Geraghty, James G, Rothwell, Jane, McCartan, Damian P, Greally, Megan, O'Connor, Miriam, O'Mahony, Deirdre, Keane, Maccon, Kennedy, Michael John, O'Reilly, Seamus, Millen, Steve J, Crown, John P, Kelly, Catherine M, Prichard, Ruth S, Quinn, Cecily M, Walshe, Janice M

Volltext

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers von Bianchini, Giampaolo, Pusztai, Lajos, Karn, Thomas, Iwamoto, Takayuki, Rody, Achim, Kelly, Catherine, Müller, Volkmar, Schmidt, Schmidt, Qi, Yuan, Holtrich, Uwe, Becker, Sven, Santarpia, Libero, Fasolo, Angelica, Del Conte, Gianluca, Zambetti, Milvia, Sotiriou, Christos, Haibe-Kains, Benjamin, Symmans, W Fraser, Gianni, Luca

Volltext

Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric field von Kelly, Catherine M., Northey, Thomas, Ryan, Kate, Brooks, Bernard R., Kholkin, Andrei L., Rodriguez, Brian J., Buchete, Nicolae-Viorel

Volltext

Oligometastatic breast cancer: Are we there yet? von AlSendi, Maha, O'Reilly, David, Zeidan, Youssef H., Kelly, Catherine M.

Volltext

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial von Galactionova, Katya, Loibl, Sibylle, Salari, Paola, Marmé, Frederik, Martin, Miguel, Untch, Michael, Bonnefoi, Hervé R., Kim, Sung-Bae, Bear, Harry D., McCarthy, Nicole, Gelmon, Karen A., García-Sáenz, José A., Kelly, Catherine M., Reimer, Toralf, Toi, Masakazu, Rugo, Hope S., Gnant, Michael, Makris, Andreas, Burchardi, Nicole, Schwenkglenks, Matthias

Volltext

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer von O Leary, Patrick C, Penny, Sarah A, Dolan, Roisin T, Kelly, Catherine M, Madden, Stephen F, Rexhepaj, Elton, Brennan, Donal J, McCann, Amanda H, Pontén, Fredrik, Uhlén, Mathias, Zagozdzon, Radoslaw, Duffy, Michael J, Kell, Malcolm R, Jirström, Karin, Gallagher, William M

Volltext

“Candidatus Mycoplasma haemomacaque” and Bartonella quintana Bacteremia in Cynomolgus Monkeys von Maggi, Ricardo G, Mascarelli, Patricia E, Balakrishnan, Nandhakumar, Rohde, Cynthia M, Kelly, Catherine M, Ramaiah, Lila, Leach, Michael W, Breitschwerdt, Edward B

Volltext

Spatial predictors of immunotherapy response in triple-negative breast cancer von Wang, Xiao Qian, Danenberg, Esther, Huang, Chiun-Sheng, Egle, Daniel, Callari, Maurizio, Bermejo, Begoña, Dugo, Matteo, Zamagni, Claudio, Thill, Marc, Anton, Anton, Zambelli, Stefania, Russo, Stefania, Ciruelos, Eva Maria, Greil, Richard, Győrffy, Balázs, Semiglazov, Vladimir, Colleoni, Marco, Kelly, Catherine M., Mariani, Gabriella, Del Mastro, Lucia, Biasi, Olivia, Seitz, Robert S., Valagussa, Pinuccia, Viale, Giuseppe, Gianni, Luca, Bianchini, Giampaolo, Ali, H. Raza

Volltext

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial von Loibl, Sibylle, Marmé, Frederik, Martin, Miguel, Untch, Michael, Bonnefoi, Hervé, Kim, Sung-Bae, Bear, Harry, McCarthy, Nicole, Melé Olivé, Mireia, Gelmon, Karen, García-Sáenz, José, Kelly, Catherine M, Reimer, Toralf, Toi, Masakazu, Rugo, Hope S, Denkert, Carsten, Gnant, Michael, Makris, Andreas, Koehler, Maria, Huang-Bartelett, Cynthia, Lechuga Frean, Maria Jose, Colleoni, Marco, Werutsky, Gustavo, Seiler, Sabine, Burchardi, Nicole, Nekljudova, Valentina, von Minckwitz, Gunter

Volltext

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer von KELLY, Catherine M, GREEN, Marjorie C, HUNT, Kelly K, HORTOBAGYI, Gabriel N, BUZDAR, Aman U, BROGLIO, Kristine, THOMAS, Eva S, BREWSTER, Abenaa M, VALERO, Vicente, IBRAHIM, Nuhad K, GONZALEZ-ANGULO, Ana M, BOOSER, Daniel J, WALTERS, Ronald S

Volltext

The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study... von Donohoe, Fionán, O'Meara, Yvonne, Roberts, Aidin, Comerford, Louise, Kelly, Catherine M., Walshe, Janice M., Peate, Michelle, Hickey, Martha, Brennan, Donal J.

Volltext

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish cent... von Prior, Lisa, Featherstone, Hannah, O'Reilly, David, Nugent, Killian, Lim, Marvin, McCaffrey, John, Higgins, Michaela J, Kelly, Catherine M

Volltext

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer von Krop, Ian, Abramson, Vandana, Colleoni, Marco, Traina, Tiffany, Holmes, Frankie, Garcia-Estevez, Laura, Hart, Lowell, Awada, Ahmad, Zamagni, Claudio, Morris, Patrick G, Schwartzberg, Lee, Chan, Stephen, Gucalp, Ayca, Biganzoli, Laura, Steinberg, Joyce, Sica, Lorenzo, Trudeau, Maureen, Markova, Denka, Tarazi, Jamal, Zhu, Zhou, O'Brien, Thomas, Kelly, Catherine M, Winer, Eric, Yardley, Denise A

Volltext

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer von Santarpia, Libero, Bottai, Giulia, Kelly, Catherine M., Győrffy, Balázs, Székely, Borbala, Pusztai, Lajos

Volltext